以作用機轉為基礎之標靶藥物在眼科治療之角色
標靶治療是近年來疾病的新興治療策略，廣義而言是瞄準特定的致病機轉，治療疾病本身並同時降低副作用。本文首先介紹ROCK抑制劑、鈣調磷酸酶抑制劑（calcineurin inhibitors）、整合素抑制劑（integrin inhibitors）、抗血管內皮生長因子藥物（anti-VEGF therapies）等藥物於眼科的應用。接著討論眼科癌症，包括眼內淋巴癌與葡萄膜黑色素瘤的標靶治療。上述藥物參與的生理作用涵蓋血管新生、免疫反應與致癌機制。本文主要介紹這些標靶藥物的藥理機轉與新藥在疾病治療上的角色，並輔以當前的尚待克服的挑戰與研究目標，期待結合這些基礎藥理機轉與臨床治療上的證據，可指引未來眼...
Saved in:
| Published in | 台灣醫學 Vol. 25; no. 4; pp. 493 - 498 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | Chinese |
| Published |
台灣
臺灣醫學會
25.07.2021
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1028-1916 |
| DOI | 10.6320/FJM.202107_25(4).0007 |
Cover
| Abstract | 標靶治療是近年來疾病的新興治療策略，廣義而言是瞄準特定的致病機轉，治療疾病本身並同時降低副作用。本文首先介紹ROCK抑制劑、鈣調磷酸酶抑制劑（calcineurin inhibitors）、整合素抑制劑（integrin inhibitors）、抗血管內皮生長因子藥物（anti-VEGF therapies）等藥物於眼科的應用。接著討論眼科癌症，包括眼內淋巴癌與葡萄膜黑色素瘤的標靶治療。上述藥物參與的生理作用涵蓋血管新生、免疫反應與致癌機制。本文主要介紹這些標靶藥物的藥理機轉與新藥在疾病治療上的角色，並輔以當前的尚待克服的挑戰與研究目標，期待結合這些基礎藥理機轉與臨床治療上的證據，可指引未來眼科精準治療的方向。 |
|---|---|
| AbstractList | Targeted therapies have become emerging treatment strategies for various ocular diseases. These treatments exploit novel targets and mechanisms with an aim to better control the diseases with reduced adverse effects. In this article, we introduced the application of targeted therapy in ophthalmology, including ROCK (Rho-kinase) inhibitors, calcineurin inhibitors, integrin inhibitors and anti-VEGF(vascular endothelial growth factor) therapies. We also discussed targeted therapies for ocular cancers including primary intraocular lymphoma and uveal melanoma. These topics cover a wide spectrum of biological processes, such as vascular proliferation, immune response and oncogenesis. For each topic, we briefly presented the underlying mechanisms, along with the corresponding drugs and their role in current ocular disease regimens. We further included some ongoing challenges and research directions to solve them. Combining these pharmacological knowledge and clinical evidence may shed light on ideas towards future p 標靶治療是近年來疾病的新興治療策略，廣義而言是瞄準特定的致病機轉，治療疾病本身並同時降低副作用。本文首先介紹ROCK抑制劑、鈣調磷酸酶抑制劑（calcineurin inhibitors）、整合素抑制劑（integrin inhibitors）、抗血管內皮生長因子藥物（anti-VEGF therapies）等藥物於眼科的應用。接著討論眼科癌症，包括眼內淋巴癌與葡萄膜黑色素瘤的標靶治療。上述藥物參與的生理作用涵蓋血管新生、免疫反應與致癌機制。本文主要介紹這些標靶藥物的藥理機轉與新藥在疾病治療上的角色，並輔以當前的尚待克服的挑戰與研究目標，期待結合這些基礎藥理機轉與臨床治療上的證據，可指引未來眼科精準治療的方向。 |
| Author | 劉欣瑜(Hsin-Yu Liu) 謝德威(Te-Wei Shieh) 王忠鈺(Chung-Yu Wang) |
| Author_xml | – sequence: 1 fullname: 謝德威(Te-Wei Shieh) – sequence: 2 fullname: 王忠鈺(Chung-Yu Wang) – sequence: 3 fullname: 劉欣瑜(Hsin-Yu Liu) |
| BookMark | eNpVkE9LAlEUxd_CIDO_Qe1rMXbvm_dvVhGSWRgtaj-8ySdOhIIW4dadBEERhGC4SdStiyDNb6O-6Vs0Zi1aXA73_OByz9kgiUq1YgjZRsgIl8Je7uQ0Q4EiSJ_yHbabAQCZIEkEqhz0UKyTdL0eBoCSCnRBJcn-bNKbTTv2ebAYdqNpyzbH8-7Yvj3MPu4Xg_bX63v00rOt4bwzsJ1P239cjCa23Yxp1H-KWqNNslbS13WT_tUUOc8dXmTzTuHs6Dh7UHC0EtzRYLimGgIOSA16UirDJBeCGSGZ0NRQZIqXJEJRXXqxI6Sk4KJiiCxwU2RrdbXcuDOBX27UjC76ANxzweMxzq-wDmvhTehfVW9rlfgbfxl8mdv_a-VHqIh74f8X5rnxKPcb6flwuQ |
| ContentType | Journal Article |
| DBID | 188 9RA |
| DOI | 10.6320/FJM.202107_25(4).0007 |
| DatabaseName | Airiti Library HyRead台灣全文資料庫 |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | The Role of Mechanism-Based Target Therapy in Ophthalmology |
| DocumentTitle_FL | The Role of Mechanism-Based Target Therapy in Ophthalmology |
| EndPage | 498 |
| ExternalDocumentID | 00593095 10281916_202107_202107260005_202107260005_493_498 |
| GroupedDBID | 188 ALMA_UNASSIGNED_HOLDINGS M~E 9RA |
| ID | FETCH-LOGICAL-a865-a0e5a2a0b5012e19778e475664e6746a2e21485f710d8c946a677203184114b3 |
| ISSN | 1028-1916 |
| IngestDate | Thu Jul 31 12:28:09 EDT 2025 Tue Oct 01 22:51:10 EDT 2024 |
| IsPeerReviewed | false |
| IsScholarly | false |
| Issue | 4 |
| Keywords | targeted therapy ROCK 標靶治療 VEGF uveal melanoma 整合素 calcineurin Rho相關蛋白酶 鈣調磷酸酶抑制劑 抗血管內皮生長因子 葡萄膜黑色素瘤 眼內淋巴癌 integrin intraocular lymphoma |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-a865-a0e5a2a0b5012e19778e475664e6746a2e21485f710d8c946a677203184114b3 |
| PageCount | 6 |
| ParticipantIDs | hyweb_hyread_00593095 airiti_journals_10281916_202107_202107260005_202107260005_493_498 |
| PublicationCentury | 2000 |
| PublicationDate | 20210725 |
| PublicationDateYYYYMMDD | 2021-07-25 |
| PublicationDate_xml | – month: 07 year: 2021 text: 20210725 day: 25 |
| PublicationDecade | 2020 |
| PublicationPlace | 台灣 |
| PublicationPlace_xml | – name: 台灣 |
| PublicationTitle | 台灣醫學 |
| PublicationTitle_FL | Formosan Journal of Medicine |
| PublicationYear | 2021 |
| Publisher | 臺灣醫學會 |
| Publisher_xml | – name: 臺灣醫學會 |
| SSID | ssib017261308 ssib002263207 ssib008679384 ssib004318135 ssib044762447 |
| Score | 1.8456854 |
| Snippet | 標靶治療是近年來疾病的新興治療策略，廣義而言是瞄準特定的致病機轉，治療疾病本身並同時降低副作用。本文首先介紹ROCK抑制劑、鈣調磷酸酶抑制劑（calcineurin inhibitors）、整合素抑制劑（integrin inhibitors）、抗血管內皮生長因子藥物（anti-VEGF... Targeted therapies have become emerging treatment strategies for various ocular diseases. These treatments exploit novel targets and mechanisms with an aim to... |
| SourceID | hyweb airiti |
| SourceType | Publisher |
| StartPage | 493 |
| SubjectTerms | calcineurin integrin intraocular lymphoma Rho相關蛋白酶 ROCK targeted therapy TSCI uveal melanoma VEGF 抗血管内皮生長因子 整合素 標革巴治療 眼内淋巴癌 葡萄膜黑色素瘤 鈣調麟酸酶抑制劑 |
| Title | 以作用機轉為基礎之標靶藥物在眼科治療之角色 |
| URI | https://www.airitilibrary.com/Article/Detail/10281916-202107-202107260005-202107260005-493-498 http://www.hyread.com.tw/hypage.cgi?HYPAGE=search/search_detail_new.hpg&dtd_id=3&sysid=00593095 |
| Volume | 25 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1NT9RAtAG8eDEaMeJXODiJhhTb2ZnOzMm0SzeEiBcx4GnTdtvsXiAR9gAHD9yIiYnGxJBguEiAKwcTQf4N0PVf-N5r2S1GEzEetjs7M-9rpp157-2bPst6KJLYk5Jnto4MGChRLbGNSZWdCKVi3uIqytDfMfvcm34pZhbkwtBwVola6q7Ek8nab8-V_MusQh3MK56SvcTM9pFCBZRhfuEKMwzXv5pjFgoWBMyXVJhips5CxYxgvmahx3zDTIOFGpu0wSbNWeCzUGI9FhTzQZcMCdwwHRCUZgY6A-wUCzwEN4pIKEQCOBG8TiQUFgIi6kPZRfCAI0vYZJDcALOmPhwLgCfgVbUYcWpgySEqLvNryIAGZgJs8oGTfsgtYaojd9AShCxQ1EUjHNdzqT2fdiYwxXe74uUgvCHxAUAN5jtEQOMocF1vw5Jnv-pOzJP3vAIFbPk0dh7SRLZIThCb6-nlziICPet0z2FK9wl30S9bHLWmG56EVuWQ_0E-pAF4i4Q75T6BTkkwdb3qRlKi7VS9JLQriCIJZKlgiCLt9q97l1fjGOzZmJmdRD4d1cTEVFqABPiSTTXYsPthlMgFMtE8B6AvTDngyIs_gAP46GHrCleKwhlm34QVNQ6JV_79hoXerajR-FLG2uA8M-i8aHX2120hYEcVlMuvPy7FYTlE--SCRI_EY5IGFL6og6_tAqOwvVqEH59rdXPXrWulOTbuF8_WDWtorX3TenpytHNyvJV_3Dvb3-4db-Trh6fbh_mXdyff3p7tbf74_LX3aSff2D_d2su3vue7788OjvLNdWjt7X7obRyMWi8a4Vx92i4TjdiR9qQdOamMeOTEErS11AWLSKdCgZ0jUk8JL-Ipd4WWGSjjLZ0YqPEURi-4WriuiGu3rJHFpcX0tjWuM62yVCUtyR0RKzdOMF1DJkXSUq7MsjHLL6RulqvIcvPSczhmjdKANdurYFa2mpSUEwylO_8B913r6uAZuWeNrLzupvdB6V6JH9Ad8xM6h6D1 |
| linkProvider | ISSN International Centre |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E4%BB%A5%E4%BD%9C%E7%94%A8%E6%A9%9F%E8%BD%89%E7%82%BA%E5%9F%BA%E7%A4%8E%E4%B9%8B%E6%A8%99%E9%9D%B6%E8%97%A5%E7%89%A9%E5%9C%A8%E7%9C%BC%E7%A7%91%E6%B2%BB%E7%99%82%E4%B9%8B%E8%A7%92%E8%89%B2&rft.jtitle=%E5%8F%B0%E7%81%A3%E9%86%AB%E5%AD%B8&rft.au=%E8%AC%9D%E5%BE%B7%E5%A8%81%28Te-Wei+Shieh%29&rft.au=%E7%8E%8B%E5%BF%A0%E9%88%BA%28Chung-Yu+Wang%29&rft.au=%E5%8A%89%E6%AC%A3%E7%91%9C%28Hsin-Yu+Liu%29&rft.date=2021-07-25&rft.pub=%E8%87%BA%E7%81%A3%E9%86%AB%E5%AD%B8%E6%9C%83&rft.issn=1028-1916&rft.volume=25&rft.issue=4&rft.spage=493&rft.epage=498&rft_id=info:doi/10.6320%2FFJM.202107_25%284%29.0007&rft.externalDocID=10281916_202107_202107260005_202107260005_493_498 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fwww.airitilibrary.com%2Fjnltitledo%2F10281916-c.jpg |